Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes

Biochemical Journal

Volumn 374, Issue 2, 2003, Pages 453-461

  Jupp, Orla J ^a   Vandenabeele, Peter ^b   MacEwan, David J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Apoptosis; Cytokine receptor; Phosphatase; Protein kinase; Signal transduction

Indexed keywords

ENZYMES; PLASMAS;

PLASMA MEMBRANES;

TUMORS;

CALCIUM ION; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD; ARACHIDONIC ACID; CALCIUM; CYTOSOL; ENDOPEPTIDASES; ENZYME ACTIVATION; HELA CELLS; HUMANS; HYDROLYSIS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR CELLS, CULTURED;

EID: 0041829104     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20030705     Document Type: Article

References (54)

1. 2 from the human monocytic cell-line U937. Proc. Natl. Acad. Sci. U.S.A. 87, 7708-7712
2. 2+-dependent translocation domain with homology to PKC and GAP. Cell (Cambridge, Mass.) 65, 1043-1051
3. 2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem. 266, 5268-5272
4. 2. J. Biol. Chem. 266, 14850-14853
5. 2. Biochim. Biophys. Acta 1488, 124-138
6. 2 activity and gene-expression are stimulated by tumor-necrosis-factor - dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. U.S.A. 90, 4475-4479
7. 2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 5073-5077
8. 2 during apoptosis. J. Immunol. 161, 5687-5694
9. 2 by caspase-1 (ICE) and caspase-8 (FLICE). Biochem. Biophys. Res. Commun. 253, 92-98
10. 2 which undergoes proteolytic inactivation. J. Biol. Chem. 273, 13870-13877
11. Jaattela, M., Wissing, D., Kokholm, K., Kallunki, T. and Egeblad, M. (1998) Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J. 17, 6124-6134
12. 2. J. Immunol. 165, 6756-6761
13. 2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS Lett. 379, 77-81
14. 2 as defined by gene knockouts. Biochim. Biophys. Acta 1488, 139-148
15. Vandenabeele, P., Declercq, W., Beyaert, R. and Fiers, W. (1995) 2 Tumor-necrosis-factor receptors - structure and function. Trends Cell Biol. 5, 392-399
16. MacEwan, D. J. (2002) TNF ligands and receptors - a matter of life and death. Br. J. Pharmacol. 135, 855-875
17. Grell, M., Douni, E., Wajant, H, Lohden, M., Clauss, M., Maxeiner, B, Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K. et al. (1995) The transmembrane form of tumor-necrosis-factor is the prime activating ligand of the 80 kDa tumor-necrosis-factor receptor. Cell (Cambridge, Mass.) 83, 793-802
18. Jupp, O. J., McFarlane, S. M., Anderson, H. M., Littlejohn, A. F., Mohamed, A. A. A., MacKay, R. H., Vandenabeele, P. and MacEwan, D. J. (2001) Type II tumour necrosis factor-α receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem. J. 359, 525-535
19. 2 correlate with lymphocyte maturation. J. Immunol. 156, 2054-2061
20. Dole, V. P. and Meinertz, H. (1960) Microdetermination of long-chain fatty acids in plasma and tissues. J. Biol. Chem. 235, 2595-2599
21. McFarlane, S. M., Jupp, O. J., Cobban, H. J., Hunter, I., Anderson, H. M., Vandenabeele, P., Nixon, G. F. and MacEwan, D. J. (2001) Stimulation of stress-activated but not mitogen-activated protein kinases by tumour necrosis factor receptor subtypes in airway smooth muscle. Biochem. Pharmacol. 61, 749-759
22. McFarlane, S. M., Anderson, H. M., Tucker, S. J., Jupp, O. J. and MacEwan, D. J. (2000) Unmodified calcium concentrations in tumour necrosis factor receptor subtype-mediated apoptotic cell death. Mol. Cell. Biochem. 211, 19-26
23. 2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab. Invest. 74, 684-695
24. 2 in agonist-stimulated human platelets and HeLa cells. J. Biol. Chem. 273, 4449-4458
25. Baxter, G. T., Kuo, R. C., Jupp, O. J., Vandenabeele, P. and MacEwan, D. J. (1999) Tumor necrosis factor-α, mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J. Biol. Chem. 274, 9539-9547
26. Mohamed, A. A. A., Jupp, O. J., Andersen, H. M., Littlejohn, A. F. Vandenabeele, P. and MacEwan, D. J. (2002) Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not. Biochem. J. 366, 144-155
27. 2 is phosphorylated and activated by MAP kinase. Cell (Cambridge, Mass.) 72, 269-278
28. 2 by p42 microtubule-associated protein-2 kinase and protein-kinase-C. J. Biol. Chem. 268, 1960-1964
29. 2 in human platelets. J. Biol. Chem. 268, 26796-26804
30. 2. J. Biol. Chem. 271, 27723-27729
31. 2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem. J. 319, 17-20
32. 2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur. J. Biochem. 245 751-759
33. 2 and the release of arachidonic acid in human neutrophils. J. Immunol. 162, 2334-2340
34. 2 activity by either Fcγ RIIa or Fcγ RIIIb in human neutrophils - a possible role for Pyk2 but not for the Grb2-Sos-Shc complex. J. Biol. Chem. 275, 12416-12423
35. 2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270, 30749-30754
36. 2 from cytosol to the nuclear-envelope in rat basophilic leukemia-cells stimulated with calcium ionophore or IgE/antigen. J. Biol. Chem. 270, 15359-15367
37. 2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. Biochem. J. 318, 797-803
38. 2. J. Biol. Chem. 274, 5163-5169
39. 2. Biochim. Biophys. Acta 1488, 40-47
40. Kramer, R. M., Roberts, E. F., Strifler, B. A. and Johnstone, E. M. (1995) Thrombin induces activation of p38 MAP kinase in human platelets. J. Biol. Chem. 270, 27395-27398
41. Schievella, A. R., Chen, J. H., Graham, J. R. and Lin, L.-L. (1997) MADD, a novel death domain protein that interacts with the type 1 tumour necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 272, 12069-12075
42. Decoster, E., Vanhaesebroeck, B., Vandenabeele, P., Grooten, J. and Fiers, W. (1995) Generation and biological characterization of membrane-bound, uncleavable murine tumor-necrosis-factor. J. Biol. Chem. 270, 18473-18478
43. Wajant, H., Grell, M. and Scheurich, P. (1999) TNF receptor associated factors in cytokine signaling. Cytokine Growth Factor Rev. 10, 15-26
44. 2 activity, but not with arachidonic-acid release per-se. Eur. J. Biochem. 195, 465-475
45. 2 is crucial in the cytotoxic action of tumor-necrosis-factor. J. Biol. Chem. 268, 11290-11295
46. 2 in human melanoma tumor cells. J. Immunol. 156, 201-207
47. 2 causes TNF resistance in human leukemic cells. J. Immunol. 160, 5929-5935
48. 2. Cancer Res. 58, 633-640
49. Devalck, D., Vercammen, D., Fiers, W. and Beyaert, R. (1998) Differential activation of phospholipases during necrosis or apoptosis: a comparative study using tumor necrosis factor and anti-Fas antibodies. J. Cell. Biochem. 71, 392-399
50. 2 accompanies cycloheximide- and adenovirus-induced susceptibility to TNF. J. Immunol. 161, 1525-1532
51. Chang, D. J., Ringold, G. M. and Heller, R. A. (1992) Cell killing and induction of manganous superoxide-dismutase by tumor-necrosis-factor-α is mediated by lipoxygenase metabolites of arachidonic-acid. Biochem. Biophys. Res. Commun. 188, 538-546
52. Reid, T., Louie, P. and Heller, R. A. (1994) Mechanisms of tumor-necrosis-factor cytotoxicity and the cytotoxic signals transduced by the p75-tumor necrosis factor-receptor. Circ. Shock 44, 84-90
53. 2-linked cascade. J. Biol. Chem. 275, 32357-32362
54. 2 is necessary for tumor necrosis factor α-induced ceramide generation in L929 cells. J. Biol. Chem. 272, 17196-17203